Crawford A B, Regnis J, Laks L, Donnelly P, Engel L A, Young I H
Dept of Respiratory Medicine, Westmead Hospital, Sydney, Australia.
Eur Respir J. 1995 Dec;8(12):2015-21. doi: 10.1183/09031936.95.08122015.
To test the hypothesis that diffusion-limitation for oxygen is due to abnormal vascular dilatation and significantly contributes to the arterial hypoxaemia of liver cirrhosis requires an experimental approach that detects both diffusion-limitation for oxygen and the presence of abnormal dilatation of pulmonary vessels exposed to alveolar gas. We therefore studied the gas exchange of a 64 year old man with alcoholic liver cirrhosis and severe resting arterial hypoxaemia (arterial oxygen tension (Pa,O2) 7.5 kPa) whilst breathing air and 100% O2 using conventional blood gas (CBG) analysis, the multiple inert gas elimination technique (MIGET) and whole body scintigraphy (WBS) following the i.v. administration of radiolabelled boli of macroaggregates with a minimum diameter of 15 microM. During air breathing, there was a consistently positive difference between the arterial oxygen tension predicted by MIGET and that actually measured (P-M Pa,O2, average 0.9 kPa). During O2 breathing, P-M Pa,O2 became negative, (average -12.2 kPa), and shunt estimated by the O2 method (% of Q') was consistently less than that measured by MIGET. Whereas both O2 method and MIGET estimates of shunt never exceeded 25%, the WBS shunt was 40%, indicating that a substantial fraction of cardiac output flowed through abnormally dilated pulmonary vessels, some of which were exposed to alveolar gas and, hence, participated in gas exchange. Although our observations pertain to one subject, we believe they provide the most convincing in vivo evidence to date that abnormal dilatation of interalveolar vessels may, per se, result in a significant diffusion impairment for O2. Furthermore, in view of the consistently negative P-M Pa,O2 observed during oxygen breathing, we speculate that such abnormal vascular dilatation may also have produced a significant diffusive impairment of one or more of the less soluble inert gases used in the MIGET analysis.
为了验证氧弥散受限是由于异常血管扩张所致且对肝硬化患者的动脉低氧血症有显著影响这一假说,需要一种实验方法来检测氧弥散受限以及暴露于肺泡气中的肺血管异常扩张情况。因此,我们使用传统血气分析(CBG)、多种惰性气体排除技术(MIGET)和全身闪烁扫描(WBS),在静脉注射最小直径为15微米的放射性标记大聚合体后,对一名64岁患有酒精性肝硬化且静息时存在严重动脉低氧血症(动脉血氧分压(Pa,O2)为7.5 kPa)的男性进行了气体交换研究。在呼吸空气时,MIGET预测的动脉血氧分压与实际测量值之间始终存在正差值(P-M Pa,O2,平均为0.9 kPa)。在呼吸氧气时,P-M Pa,O2变为负值(平均为-12.2 kPa),并且用氧法估算的分流(Q'的百分比)始终低于MIGET测量值。虽然氧法和MIGET估算的分流均未超过25%,但WBS分流为40%,这表明相当一部分心输出量流经异常扩张的肺血管,其中一些血管暴露于肺泡气中并参与了气体交换。尽管我们的观察仅涉及一名受试者,但我们认为它们提供了迄今为止最有说服力的体内证据,表明肺泡间血管的异常扩张本身可能导致氧的显著弥散障碍。此外,鉴于在呼吸氧气时观察到的P-M Pa,O2始终为负,我们推测这种异常血管扩张也可能对MIGET分析中使用的一种或多种溶解度较低的惰性气体产生显著的弥散障碍。